The genetic basis of Ro and La antibody formation in systemic lupus erythematosus. Results of a multicenter study. The SLE Study Group

Rheumatol Int. 1992;11(6):243-9. doi: 10.1007/BF00301501.


Antibodies against Ro and La, including recombinant La and recombinant 60 kD-Ro, were determined by counter immunoelectrophoresis and ELISA in over 300 central European systemic lupus erythematosus (SLE) patients. The presence of both Ro and La antibodies was strongly associated with the MHC haplotype B8-C4AQ0-DR3-DQ2, the association being strongest for DR3. After exclusion of all B8-DR3 positive patients only DR3 positive patients still showed an increased incidence of Ro and La antibodies, suggesting DR3 as the primary association factor. High titers of La antibody, but not of 60 kD-Ro antibody, were also significantly associated with the presence of DR3. Other DR and DQ antigens or heterozygous DQ combinations were not significantly associated with Ro and La antibodies.

Publication types

  • Clinical Trial
  • Multicenter Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antibodies, Antinuclear / analysis
  • Antibodies, Antinuclear / immunology*
  • Antibody Formation
  • Counterimmunoelectrophoresis
  • Enzyme-Linked Immunosorbent Assay
  • HLA Antigens / immunology
  • HLA-DR Antigens / immunology
  • Humans
  • Immunogenetics
  • Lupus Erythematosus, Systemic / immunology


  • Antibodies, Antinuclear
  • HLA Antigens
  • HLA-DR Antigens
  • SS-A antibodies
  • SS-B antibodies